High baseline soluble urokinase plasminogen activator receptor (suPAR) serum levels indicate adverse outcome after resection of pancreatic adenocarcinoma
We show that elevated levels of circulating suPAR in patients with resectable pancreatic adenocarcinoma are associated with a significantly impaired overall sur
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
08 February 2019
|
| In: |
Carcinogenesis
Year: 2019, Volume: 40, Issue: 8, Pages: 947-955 |
| ISSN: | 1460-2180 |
| DOI: | 10.1093/carcin/bgz033 |
| Online Access: | Verlag, Volltext: https://doi.org/10.1093/carcin/bgz033 Verlag, Volltext: https://academic.oup.com/carcin/article/40/8/947/5364809 
|
| Author Notes: | Sven H. Loosen, Frank Tacke, Niklas Püthe, Marcel Binneboesel, Georg Wiltberger, Patrick H. Alizai, Jakob N. Kather, Pia Paffenholz, Thomas Ritz, Alexander Koch, Frank Bergmann, Christian Trautwein, Thomas Longerich, Christoph Roderburg, Ulf P. Neumann, Tom Luedde |
| Summary: | We show that elevated levels of circulating suPAR in patients with resectable pancreatic adenocarcinoma are associated with a significantly impaired overall sur |
|---|---|
| Item Description: | Gesehen am 04.12.2019 |
| Physical Description: | Online Resource |
| ISSN: | 1460-2180 |
| DOI: | 10.1093/carcin/bgz033 |